IQVIA (NYSE:IQV) Price Target Lowered to $210.00 at Citigroup
IQVIA (NYSE:IQV – Get Free Report) had its target price decreased by equities researchers at Citigroup from $225.00 to $210.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the medical research company’s stock. Citigroup’s price objective points to a potential upside of 12.88% from the company’s previous […]
IQVIA (NYSE:IQV – Get Free Report) had its target price decreased by equities researchers at Citigroup from $225.00 to $210.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the medical research company’s stock. Citigroup’s price objective points to a potential upside of 12.88% from the company’s previous […]
